UM

Browse/Search Results:  1-4 of 4 Help

Filters    
Selected(0)Clear Items/Page:    Sort:
Inhibition of angiogenesis by selective estrogen receptor modulators through blockade of cholesterol trafficking rather than estrogen receptor antagonism Journal article
Cancer Letters, 2015,Volume: 362,Issue: 1,Page: 106-115
Authors:  Shim J.S.;  Li R.-J.;  Lv J.;  Head S.A.;  Yang E.J.;  Liu J.O.
Favorite | View/Download:6/0 | TC[WOS]:10 TC[Scopus]:0 | Submit date:2019/01/15
Angiogenesis  Cholesterol Trafficking  Selective Estrogen Receptor Modulator  Tamoxifen  
A novel anti-cancer agent, acetyltanshinone IIA, inhibits oestrogen receptor positive breast cancer cell growth by down-regulating the oestrogen receptor Journal article
Cancer Letters, 2014,Volume: 346,Issue: 1,Page: 94-103
Authors:  Yu T.;  Zhou Z.;  Mu Y.;  De Lima Lopes G.;  Luo K.Q.
Favorite | View/Download:3/0 | TC[WOS]:20 TC[Scopus]:0 | Submit date:2018/12/18
Acetyltanshinone Iia  Anti-breast Cancer Agent  Fulvestrant  Oestrogen Receptor  Tamoxifen  
IC-4, a new irreversible EGFR inhibitor, exhibits prominent anti-tumor and anti-angiogenesis activities Journal article
Cancer Letters, 2013,Volume: 340,Issue: 1,Page: 88
Authors:  Li Y.-B.;  Wang Z.-Q.;  Yan X.;  Chen M.-W.;  Bao J.-L.;  Wu G.-S.;  Ge Z.-M.;  Zhou D.-M.;  Wang Y.-T.;  Li R.-T.
Favorite | View/Download:6/0 | TC[WOS]:18 TC[Scopus]:0 | Submit date:2018/10/31
Angiogenesis  Breast Cancer  Egfr  Irreversible Tki  
A novel compound modified from tanshinone inhibits tumor growth in vivo via activation of the intrinsic apoptotic pathway Journal article
Cancer Letters, 2010,Volume: 297,Issue: 1,Page: 18-30
Authors:  Tian H.-L.;  Yu T.;  Xu N.-N.;  Feng C.;  Zhou L.-Y.;  Luo H.-W.;  Chang D.C.;  Le X.-F.;  Luo K.Q.
Favorite | View/Download:4/0 | TC[WOS]:37 TC[Scopus]:0 | Submit date:2018/12/18
Anticancer Drug  Apoptosis  Breast Cancer  Reactive Oxygen Species  Tanshinone Iia